PKM and cancer: Our recent study showed that [9] hypoxia-induced production of exosomal PKM2 reprogrammed A549 and cancer-associated fibroblasts (CAFs) to create an acidic microenvironment, which in turn promoted the proliferation and cisplatin resistance of NSCLC cells.